Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $3.63 in the prior trading day, Altimmune Inc (NASDAQ: ALT) closed at $3.56, down -1.93%. In other words, the price has decreased by -$1.93 from its previous closing price. On the day, 2.91 million shares were traded. ALT stock price reached its highest trading level at $3.63 during the session, while it also had its lowest trading level at $3.51.
Ratios:
Our goal is to gain a better understanding of ALT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 20.41 and its Current Ratio is at 20.41. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.10.
On January 08, 2025, Stifel started tracking the stock assigning a Buy rating and target price of $18.Stifel initiated its Buy rating on January 08, 2025, with a $18 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 17 ’25 when Sohn Catherine A. bought 1,000 shares for $5.78 per share. The transaction valued at 5,784 led to the insider holds 1,000 shares of the business.
WEAVER GREGORY L bought 10,000 shares of ALT for $51,996 on Mar 13 ’25. The Chief Financial Officer now owns 10,000 shares after completing the transaction at $5.20 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALT now has a Market Capitalization of 314195968 and an Enterprise Value of 146939824. For the stock, the TTM Price-to-Sale (P/S) ratio is 15710.00 while its Price-to-Book (P/B) ratio in mrq is 1.88. Its current Enterprise Value per Revenue stands at 7346.991 whereas that against EBITDA is -1.559.
Stock Price History:
The Beta on a monthly basis for ALT is 0.17, which has changed by -0.50070125 over the last 52 weeks, in comparison to a change of 0.15222645 over the same period for the S&P500. Over the past 52 weeks, ALT has reached a high of $11.16, while it has fallen to a 52-week low of $2.90. The 50-Day Moving Average of the stock is -24.34%, while the 200-Day Moving Average is calculated to be -41.15%.
Shares Statistics:
The stock has traded on average 5.70M shares per day over the past 3-months and 3004950 shares per day over the last 10 days, according to various share statistics. A total of 88.26M shares are outstanding, with a floating share count of 87.33M. Insiders hold about 1.05% of the company’s shares, while institutions hold 42.92% stake in the company. Shares short for ALT as of 1753920000 were 25760339 with a Short Ratio of 4.52, compared to 1751241600 on 31181920. Therefore, it implies a Short% of Shares Outstanding of 25760339 and a Short% of Float of 32.009998.
Earnings Estimates
A detailed examination of Altimmune Inc (ALT) is currently in progress, with 8.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.32, with high estimates of -$0.27 and low estimates of -$0.38.
Analysts are recommending an EPS of between -$0.96 and -$1.22 for the fiscal current year, implying an average EPS of -$1.12. EPS for the following year is -$1.33, with 7.0 analysts recommending between -$1.06 and -$1.55.
